(Q41715204)

7 October 2017

1 reference

title

Calcium channel blocker-induced protection against cardiovascular damage (English)

1 reference

7 October 2017

Matsumori A

1

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

International Journal of Cardiology

7 October 2017

published in

1 reference

7 October 2017

volume

62 Suppl 2

1 reference

7 October 2017

page(s)

S39-46

1 reference

Hemodynamic effects of nifedipine in congestive heart failure

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Different results in cardiopulmonary exercise tests after long-term treatment with felodipine and enalapril in patients with congestive heart failure due to ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Increased nitric oxide production in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Nitric oxide synthase activities in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Differential modulation of cytokine production by drugs: implications for therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

The challenge of cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Dilated cardiomyopathies of the adult (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Immunomodulating therapy in viral myocarditis: effects of tumour necrosis factor, interleukin 2 and anti-interleukin-2 receptor antibody in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Persistent expression of cytokine in the chronic stage of viral myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Regulation of cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Verapamil ameliorates the clinical and pathological course of murine myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Dihydropyridine Antagonists and Agonists of Calcium Channels Inhibit the Induction of Nitric Oxide Synthase by Endotoxin in Cultured Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2897%2900240-4

7 January 2021

10.1016/S0167-5273(97)00240-4

Identifiers

DOI

1 reference

7 October 2017

1 reference